Eurofins DiscoverX expands program with Catalent

By The Science Advisory Board staff writers

June 29, 2020 -- Eurofins DiscoverX has expanded its contract research organization (CRO) certification program for bioassays with Catalent Biologics as the North American provider.

From its Morrisville, NC, facility in the Research Triangle Park area, Catalent can support multiple client-sponsored good laboratory practice (GLP) validation programs using the PathHunter assay platform to conduct potency lot release assays under GLP/good manufacturing practice (GMP) conditions.

The DiscoverX program was launched to support biotechnology and pharmaceutical companies and conduct potency lot release programs for bioinnovator and biosimilar drugs. The certification provides a platform to access experienced biologics analytical labs to provide potency and neutralizing antibody study support.

Now, the bioassay certification program will play a role in helping product developers prove that their drug products are safe and effective, i.e., potent. While potency can be determined using binding assays, regulators often require functional cell-based mechanism of action-reflective assays such as PathHunter.

Catalent to provide fill-finish for Moderna's COVID-19 vaccine
Catalent will collaborate with Moderna for large-scale commercial fill-finish manufacturing of Moderna's messenger RNA-based COVID-19 vaccine candidate,...
Eurofins Discovery supports COVID-19 research
Eurofins Discovery has announced that it aims to accelerate COVID-19 antiviral drug discovery research.
Catalent completes acquisition of MaSTherCell
Catalent announced on February 11 that it has completed its acquisition of MaSTherCell Global, improving Catalent's position in the field of advanced...

Copyright © 2020 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter